References
- Bahcecioglu IH, Sahin A. Treatment of delta hepatitis: today and in the future – a review. Infect Dis (Lond). 2017;49:241–250.
- Rizzetto M, Ciancio A. Epidemiology of hepatitis D. Semin Liver Dis. 2012;32:211–219.
- Amougou MA, Noah DN, Moundipa PF, et al. A prominent role of hepatitis D virus in liver cancers documented in Central Africa. BMC Infect Dis. 2016;16:647.
- Hughes SA, Wedemeyer H, Harrison PM. Hepatitis delta virus. Lancet. 2011;378:73–85.
- Romeo R, Del Ninno E, Rumi M, et al. A 28-year study of the course of hepatitis delta infection: a risk factor for cirrhosis and hepatocellular carcinoma. Gastroenterology. 2009;136:1629–1638.
- Stockdale AJ, Chaponda M, Beloukas A, et al. Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health. 2017;5:e992–1003.
- Butler EK, Rodgers MA, Coller KE, et al. High prevalence of hepatitis delta virus in Cameroon. Sci Rep. 2018;8:11617.
- Mansour W, Bollahi M-A, Hamed C-T, et al. Virological and epidemiological features of hepatitis delta infection among blood donors in Nouakchott, Mauritania. J Clin Virol. 2012;55:12–16.
- Mansour W, Malick F-ZF, Sidiya A, et al. Prevalence, risk factors, and molecular epidemiology of hepatitis B and hepatitis delta virus in pregnant women and in patients in Mauritania. J Med Virol. 2012;84:1186–1198.
- Gal FL, Gault E, Ripault M-P, et al. Eighth major clade for hepatitis delta virus. Emerg Infect Dis. 2006;12:1447.